MetHealth CEO Dr Fiona McGillicuddy bagged the runner-up prize. Read more: Tissue repair therapeutic Substrato wins best pitch at 2026 Start-Up Day
We ask Dean Sonderegger, senior vice president & general manager of Wolters Kluwer ELM Solutions, if corporate legal teams are ready for agentic AI billing changes and how they can […] The post “Governance was designed in from day one”: Inside Wolters Kluwer’s new invoice review AI agent appeared first on Legal IT Insider.
China’s AI chatbot labs are attracting big investors, as DeepSeek is also reported to be raising at a $45bn valuation. Read more: Moonshot AI valued at $20bn after $2bn raise for Kimi creator
With the June 2026 deadline for implementing the EU’s Pay Transparency Directive just weeks away, many large member states are on track to miss it. Read more: Major European markets still lagging on salary transparency, finds report
Anthropic has ‘expressed interest’ to co-develop data centres in space, said SpaceX. Read more: Anthropic joins forces with SpaceX for Colossus capacity
Zihan Wang of the University of Sussex offers advice to professionals who want to maximise their time in shared spaces. Read more: In the flexible work era, how can we make the most of co-working spaces?
The expansion follows the organisation’s recent authorisation as an electronic money institution by the Central Bank of Ireland, providing a strategic gateway to support SMEs across the continent. Read more: Global fintech platform Currenxie to create 30 Dublin-based jobs
The agency also announced a successor to the National Digital Research Centre, which comes to a close this year. Read more: Enterprise Ireland pumped €33m into home-grown start-ups in 2025
There has been a raft of North American law firm and vendor senior appointments over the past couple of weeks, including a new global AI head at K&L Gates, a […] The post Movers and Shakers: K&L Gates; Morgan Lewis, Axinn, Eversheds, Harvey, LegalEng & Litera appeared first on Legal IT Insider.
‘Significant’ patient population unresponsive to existing schizophrenia treatments, highlighting ‘major unmet clinical need’, according to PhD researcher Keelin Harrison. Read more: Probing the link between inflammation and schizophrenia